Amethyst Pharma Limited in Camberley, GU15 3SY

Description

Data updated on: 01-11-2023

Amethyst Pharma has been offering its services for thirteen years. Started under company registration number 07509862, the firm is listed as a Private Limited Company. You can contact the headquarters of this firm during business hours under the following location: Knoll House Knoll Road, GU15 3SY Camberley. The enterprise's declared SIC number is 74909 and has the NACE code: Other professional, scientific and technical activities not elsewhere classified. March 31, 2022 is the last time when company accounts were filed.

In order to satisfy its client base, the limited company is continually being taken care of by a group of two directors who are Diljeet A. and Debra N.. Their work been of critical use to the following limited company since Thursday 6th April 2017.

Debra N. is the individual who controls this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2014-03-31	2015-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
Currency
Net Worth	208 686	372 157

Balance Sheet
Cash Bank On Hand			167 946	283 621	244 889	236 219	316 152	416 641	334 884
Current Assets	290 771	458 627	290 811	407 945	317 856	292 534	354 598	456 558	372 454
Debtors	204 450	222 650	122 865	124 324	72 967	56 315	38 446	39 917	37 570
Net Assets Liabilities			260 727	330 845	276 198	246 074	298 119	403 428	344 551
Other Debtors			4 578	15 393		16 938	27 006	20 075	934
Property Plant Equipment			1 046	3 016	2 261	5 674	8 479	7 930	5 946
Cash Bank In Hand	86 321	235 977
Net Assets Liabilities Including Pension Asset Liability	208 686	372 157
Tangible Fixed Assets	2 964	3 059

Capital & Reserves
Called Up Share Capital	100	100
Profit Loss Account Reserve	208 586	372 057
Shareholder Funds	208 686	372 157

Other Financial Data
Accrued Income								20 075	23 490
Accrued Liabilities			2 137	2 175	2 350	2 570	2 690	2 959	3 229
Accumulated Depreciation Impairment Property Plant Equipment			350	1 356	2 111	4 002	6 832	6 970	8 954
Additions Other Than Through Business Combinations Property Plant Equipment				2 976		5 304	5 635	3 093
Average Number Employees During Period			1	2	2	2	2	2	3
Creditors			30 921	79 543	43 489	51 056	63 347	59 377	32 719
Disposals Decrease In Depreciation Impairment Property Plant Equipment								-2 507
Disposals Property Plant Equipment								-3 504
Increase From Depreciation Charge For Year Property Plant Equipment				1 006	755	1 891	2 830	2 645	1 984
Net Current Assets Liabilities	206 315	369 710	259 890	328 402	274 367	241 478	291 251	397 181	339 735
Other Creditors			8 016	8 481	8 175	2 224	1 646	1 476	256
Prepayments							295	603	491
Property Plant Equipment Gross Cost			1 396	4 372	4 372	9 676	15 311	14 900	14 900
Provisions For Liabilities Balance Sheet Subtotal			209	573	430	1 078	1 611	1 683	1 130
Taxation Social Security Payable			20 768	68 442	32 964	45 721	59 011	54 287	28 533
Total Assets Less Current Liabilities	209 279	372 769	260 936	331 418	276 628	247 152	299 730	405 111	345 681
Trade Creditors Trade Payables				445		541		655	701
Trade Debtors Trade Receivables			118 287	108 931	72 967	39 377	11 145	19 239	12 655
Creditors Due Within One Year	84 456	88 917
Fixed Assets	2 964	3 059
Number Shares Allotted		100
Par Value Share		1
Provisions For Liabilities Charges	593	612
Share Capital Allotted Called Up Paid	100	100
Tangible Fixed Assets Additions		1 115
Tangible Fixed Assets Cost Or Valuation	4 468	5 583
Tangible Fixed Assets Depreciation	1 504	2 524
Tangible Fixed Assets Depreciation Charged In Period		1 020

Company staff

Diljeet A.

Role: Director

Appointed: 06 April 2017

Latest update: 14 January 2024

Debra N.

Role: Director

Appointed: 31 January 2011

Latest update: 14 January 2024

People with significant control

Debra N.

Notified on 6 April 2016

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

Diljeet A.

Notified on 6 April 2017

Ceased on 21 April 2021

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

Accounts Documents

Account next due date	31 December 2023
Account last made up date	31 March 2022
Confirmation statement next due date	14 February 2024
Confirmation statement last made up date	31 January 2023

Annual Accounts 10 December 2015
Start Date For Period Covered By Report	2014-04-01
End Date For Period Covered By Report	2015-03-31
Date Approval Accounts	10 December 2015
Annual Accounts
Start Date For Period Covered By Report	2017-04-01
End Date For Period Covered By Report	2018-03-31
Annual Accounts
Start Date For Period Covered By Report	2018-04-01
End Date For Period Covered By Report	2019-03-31
Annual Accounts
Start Date For Period Covered By Report	2019-04-01
End Date For Period Covered By Report	2020-03-31
Annual Accounts
Start Date For Period Covered By Report	2020-04-01
End Date For Period Covered By Report	2021-03-31
Annual Accounts
Start Date For Period Covered By Report	2021-04-01
End Date For Period Covered By Report	2022-03-31
Annual Accounts
Start Date For Period Covered By Report	2022-04-01
End Date For Period Covered By Report	2023-03-31

Amethyst Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Diljeet A.

Debra N.

Diljeet A.

People with significant control

Debra N.

Diljeet A.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies